Hologic
Stock Forecast, Prediction & Price Target
Hologic (HOLX) stock Price Target by analysts
$87.33
Potential upside: 29.15%
Hologic price prediction
What is Hologic stock analysts` prediction?
Hologic stock forecast: Based on 2 Wall Street analysts` predicted price targets for Hologic in the last 3 months, the avarage price target is $87.33, with a high forecast of $NaN. The average price target represents a 29.15% change from the last price of $67.62.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Hologic stock Price Target by analysts
Full breakdown of analysts given Hologic price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Anthony Petrone Mizuho Securities | 0% 0/2 | 10 months ago | $87 28.66% upside | $78.8 | StreetInsider | Previous targets (1) |
Anthony Petrone Mizuho Securities | 0% 0/2 | 11 months ago | $90 33.09% upside | $79.63 | TheFly | Previous targets (1) |
Patrick Donnelly Citigroup | 0% 0/1 | 11 months ago | $85 25.70% upside | $81.46 | TheFly | Previous targets (0) |
Mike Matson Needham | 0% 0/1 | about 1 year ago | $90 33.09% upside | $80.84 | Benzinga | Previous targets (0) |
Vijay Kumar Evercore ISI | 50% 1/2 | about 1 year ago | $76 12.39% upside | $74.1 | TheFly | Previous targets (1) |
Ian Zaffino Oppenheimer | 0% 0/1 | about 1 year ago | $33 -51.19% downside | $73.07 | Benzinga | Previous targets (0) |
David Toung Argus Research | 0% 0/1 | over 1 year ago | $95 40.49% upside | $75.86 | StreetInsider | Previous targets (0) |
Unknown Cowen & Co. | N/A | over 2 years ago | $95 40.49% upside | $83.77 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 2 years ago | $80 18.30% upside | $81.07 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 2 years ago | $75 10.91% upside | $74.22 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $70 3.51% upside | $70.86 | Benzinga | N/A |
Unknown Raymond James | N/A | about 3 years ago | $80 18.30% upside | $71.31 | Benzinga | N/A |
Unknown Leerink Partners | N/A | over 3 years ago | $85 25.70% upside | $77.22 | Benzinga | N/A |
Unknown Leerink Partners | N/A | over 3 years ago | $82 21.26% upside | $70.84 | Benzinga | N/A |
Unknown Raymond James | N/A | over 3 years ago | $83 22.74% upside | $68.42 | Benzinga | N/A |
Unknown Citigroup | N/A | over 3 years ago | $75 10.91% upside | $68.98 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 3 years ago | $75 10.91% upside | $73.93 | Benzinga | N/A |
Vijay Kumar Evercore ISI | 50% 1/2 | over 3 years ago | $80 18.30% upside | $78.34 | Pulse 2.0 | Previous targets (1) |
Anthony Petrone Jefferies | 0% 0/1 | over 3 years ago | $95 40.49% upside | $75.19 | TipRanks Contributor | Previous targets (0) |
Michael Lasser UBS | 100% 1/1 | over 4 years ago | $77 13.87% upside | $66.23 | StreetInsider | Previous targets (0) |
Hologic Financial Estimates
Hologic Revenue Estimates
Hologic EBITDA Estimates
Hologic Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/24/2022 | 9/30/2023 | 9/28/2024 | 9/30/2025 | 9/30/2026 | 9/30/2027 | 9/30/2028 |
Revenue
% change YoY
| $4.86B N/A | $4.03B -17.11% | $4.03B -0.00% | Avg: $4.24B Low: $4.20B High: $4.28B avg. 5.44% | Avg: $4.49B Low: $4.45B High: $4.53B avg. 5.82% | Avg: $4.83B Low: $4.79B High: $4.88B avg. 7.61% | Avg: $5.22B Low: $5.17B High: $5.27B avg. 8.06% |
Net Income
% change YoY
| $1.30B N/A | $456M -64.97% | $789.5M 73.13% | Avg: $857.79M Low: $818.65M High: $1.00B avg. 8.65% | Avg: $943.84M Low: $903.25M High: $1.07B avg. 10.03% | Avg: $1.37B Low: $1.36B High: $1.39B avg. 46.01% | Avg: $1.55B Low: $1.53B High: $1.57B avg. 12.84% |
EBITDA
% change YoY
| $2.10B N/A | $1.11B -47.23% | $1.29B 16.71% | Avg: $1.54B Low: $1.53B High: $1.56B avg. 19.48% | Avg: $1.63B Low: $1.62B High: $1.65B avg. 5.82% | Avg: $1.76B Low: $1.74B High: $1.77B avg. 7.61% | Avg: $1.90B Low: $1.88B High: $1.92B avg. 8.06% |
EPS
% change YoY
| $5.18 N/A | $1.85 -64.28% | $3.35 81.08% | Avg: $3.64 Low: $3.29 High: $4.02 avg. 8.63% | Avg: $4.04 Low: $3.63 High: $4.33 avg. 11.05% | Avg: $5.54 Low: $5.47 High: $5.6 avg. 37.03% | Avg: $6.25 Low: $6.17 High: $6.32 avg. 12.84% |
Operating Expenses
% change YoY
| $1.36B N/A | $1.31B -4.14% | $1.34B 2.68% | Avg: $955.37M Low: $946.36M High: $964.39M avg. -28.97% | Avg: $1.01B Low: $1.00B High: $1.01B avg. 5.82% | Avg: $1.08B Low: $1.07B High: $1.09B avg. 7.61% | Avg: $1.17B Low: $1.16B High: $1.18B avg. 8.06% |
FAQ
What is Hologic stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 19.38% in 2025-2028.
We have gathered data from 11 analysts. Their low estimate is 818.65M, average is 857.79M and high is 1.00B.
What is Hologic stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 6.73% in 2025-2028.
We have gathered data from 13 analysts. Their low revenue estimate is $4.20B, average is $4.24B and high is $4.28B.
What is Hologic stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 17.39% in 2025-2028.
We have gathered data from 11 analysts. Their low earnings per share estimate is $3.29, average is $3.64 and high is $4.02.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Hologic stock. The most successful analyst is Anthony Petrone.